ロード中...
Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
CONTEXT: Recombinant human growth hormone (rhGH) is approved for treatment of pediatric growth hormone deficiency (GHD), with greatest growth responses observed in those with severe GHD. Orally administered GH secretagogues (GHS) may be useful treatment in patients with moderate GHD. Distinguishing...
保存先:
| 出版年: | J Endocr Soc |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8101276/ https://ncbi.nlm.nih.gov/pubmed/33982678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab029 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|